Creative Planning Has $19.34 Million Holdings in HCA Healthcare, Inc. (NYSE:HCA)

Creative Planning raised its stake in HCA Healthcare, Inc. (NYSE:HCA) by 37.6% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 47,589 shares of the company’s stock after acquiring an additional 13,015 shares during the quarter. Creative Planning’s holdings in HCA Healthcare were worth $19,342,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in HCA. CreativeOne Wealth LLC acquired a new stake in shares of HCA Healthcare during the 1st quarter worth approximately $231,000. New Mexico Educational Retirement Board grew its position in shares of HCA Healthcare by 29.9% during the 1st quarter. New Mexico Educational Retirement Board now owns 13,900 shares of the company’s stock worth $4,636,000 after buying an additional 3,200 shares during the period. Kingswood Wealth Advisors LLC bought a new position in HCA Healthcare during the 1st quarter worth approximately $566,000. Bessemer Group Inc. boosted its stake in HCA Healthcare by 51.2% during the 1st quarter. Bessemer Group Inc. now owns 7,629 shares of the company’s stock worth $2,543,000 after acquiring an additional 2,584 shares during the last quarter. Finally, Empowered Funds LLC boosted its stake in HCA Healthcare by 54.3% during the 1st quarter. Empowered Funds LLC now owns 13,910 shares of the company’s stock worth $4,639,000 after acquiring an additional 4,893 shares during the last quarter. Institutional investors and hedge funds own 62.73% of the company’s stock.

Wall Street Analyst Weigh In

Several research analysts recently weighed in on the stock. UBS Group lifted their price objective on shares of HCA Healthcare from $405.00 to $438.00 and gave the stock a “buy” rating in a research note on Wednesday, August 14th. Wolfe Research raised shares of HCA Healthcare to a “strong-buy” rating in a research note on Thursday, August 29th. Truist Financial lifted their price target on shares of HCA Healthcare from $390.00 to $430.00 and gave the company a “buy” rating in a research note on Monday, August 19th. Deutsche Bank Aktiengesellschaft lifted their price target on shares of HCA Healthcare from $359.00 to $375.00 and gave the company a “buy” rating in a research note on Friday, June 28th. Finally, Barclays lifted their price target on shares of HCA Healthcare from $376.00 to $396.00 and gave the company an “overweight” rating in a research note on Wednesday, July 24th. Five research analysts have rated the stock with a hold rating, fourteen have issued a buy rating and four have issued a strong buy rating to the stock. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus target price of $365.65.

Insider Buying and Selling at HCA Healthcare

In other HCA Healthcare news, SVP Kathryn A. Torres sold 1,857 shares of the company’s stock in a transaction on Thursday, July 25th. The shares were sold at an average price of $355.05, for a total value of $659,327.85. Following the transaction, the senior vice president now directly owns 17,755 shares in the company, valued at $6,303,912.75. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. In other HCA Healthcare news, SVP Kathryn A. Torres sold 1,857 shares of the company’s stock in a transaction on Thursday, July 25th. The shares were sold at an average price of $355.05, for a total value of $659,327.85. Following the transaction, the senior vice president now directly owns 17,755 shares in the company, valued at $6,303,912.75. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, SVP Christopher F. Wyatt sold 4,000 shares of the business’s stock in a transaction dated Monday, July 29th. The shares were sold at an average price of $360.20, for a total transaction of $1,440,800.00. Following the completion of the sale, the senior vice president now directly owns 40,449 shares of the company’s stock, valued at approximately $14,569,729.80. The trade was a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 17,202 shares of company stock worth $6,407,273 over the last ninety days. Insiders own 1.60% of the company’s stock.

HCA Healthcare Price Performance

Shares of HCA opened at $410.77 on Tuesday. The company has a market cap of $107.59 billion, a price-to-earnings ratio of 20.48, a PEG ratio of 1.44 and a beta of 1.67. HCA Healthcare, Inc. has a 1-year low of $215.96 and a 1-year high of $417.14. The company’s fifty day simple moving average is $393.16 and its 200 day simple moving average is $351.09. The company has a current ratio of 1.06, a quick ratio of 0.94 and a debt-to-equity ratio of 27.11.

HCA Healthcare (NYSE:HCA) last released its quarterly earnings data on Tuesday, July 23rd. The company reported $5.50 EPS for the quarter, beating the consensus estimate of $4.97 by $0.53. HCA Healthcare had a net margin of 8.40% and a return on equity of 553.13%. The firm had revenue of $17.49 billion for the quarter, compared to the consensus estimate of $17.05 billion. During the same period in the previous year, the company earned $4.29 earnings per share. The company’s quarterly revenue was up 10.3% on a year-over-year basis. On average, research analysts forecast that HCA Healthcare, Inc. will post 22.51 earnings per share for the current fiscal year.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.